The "chicken"-there is an underlying abnormality within the hippocampus or its connections that predisposes to the development of mesial temporal lobe epilepsy, sometimes with inconsequential childhood febrile status epilepticus.
The "egg"-childhood febrile status epilepticus itself causes the initial damage that in some children progresses to hippocampal sclerosis and the eventual development of mesial temporal lobe epilepsy.
In this issue of Neurology ® , Shinnar and colleagues 1 report the results of brain MRIs in a longterm prospective study of a cohort of 191 children (1 month to 5 years old) with febrile status epilepticus (FEBSTAT). Twenty-two (11.5%) had abnormal increased T2 signal within one hippocampus at the time of the seizures compared to none of 96 children in the control group (first simple febrile seizure). This finding suggests that, in a subset of children with febrile status epilepticus who presumably had no baseline developmental brain abnormalities, recurrent seizures are the "egg," causing acute injury in at least one hippocampus, potentially leading to subsequent hippocampal sclerosis and the development of mesial temporal lobe epilepsy later in childhood or in adulthood.
Also, in the FEBSTAT study, 20 of the children in the febrile status epilepticus group had "developmental" abnormalities identified on the MRI, with hippocampal malrotation, present in 15, being the most common; only 2 of the controls had hippocampal malrotation. Such a developmental malformation could be the "chicken" in these children predisposing to febrile status epilepticus, an incidental but unnecessary step in the natural history of later mesial temporal lobe epilepsy.
Importantly, there was minimal overlap in these 2 groups, with only 2 of the participants with hippocampal high T2 signal having a hippocampal developmental abnormality. Thus, both "chicken" and "egg" mechanisms may exist, and these seem to be independent in most affected individuals.
It should be kept in mind that 67% of children with febrile status epilepticus in the FEBSTAT cohort did not have an MRI-visible brain abnormality, either acute or developmental. It is not known if current MRI technology is not adequate to identify the pathologic processes in this group, or if these children are less likely than the other groups to develop temporal lobe epilepsy. Additionally, focal EEG slow activity was associated with hippocampal T2 signal abnormalities but not hippocampal developmental abnormalities in the FEBSTAT cohort.
2 EEG may serve as another tool to differentiate those at risk for later epilepsy.
Shinnar and colleagues have started us on a path toward a better understanding of childhood febrile status epilepticus with a fairly robust initial cohort. Since 21% to 49% of children with focal febrile status epilepticus eventually develop epilepsy, 3 in 5, 10, or 15 years, the FEBSTAT participants may provide us the answer to the chicken/egg question.
DOES IT MATTER?
Recently reported from the FEBSTAT study are the results of virology studies for HHV6 and HHV7. 4 These viruses are associated with febrile seizures, particularly those that are more severe. 5, 6 They identified viremia with HHV-6B in 32% and with HHV-7 in 7%, with no differences among those infected in other characteristics, including imaging. Will it turn out that acute infection with one of these viruses, possibly in association with one of the features on MRI, leads to the eventual development of mesial temporal lobe epilepsy? If so, an opportunity may exist to develop a treatment that prevents epilepsy.
There is a precedent of a true "antiepilepsy" therapy that is now in common use preventing "febrile seizures" and subsequent temporal lobe epilepsy: the Haemophilus influenzae type B (Hib) vaccine that was approved in the United States in 1988. Through the 1990s, medically intractable mesial temporal lobe epilepsy with hippocampal sclerosis developing
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10 -20 years following childhood Hib meningitis (often presenting with febrile seizures) was commonly seen in epilepsy centers. 7 Hib meningitis as a cause of temporal lobe epilepsy has largely disappeared in the new millennium, related to the near elimination of Hib invasive disease by the Hib vaccine. Among children younger than 5 years, the Hib vaccine decreased the incidence of invasive Hib infections by 99% from 1988 to 1997, with most of the reduction occurring by 1992. 8 The nearly complete elimination of Hib meningitis seems to have manifested 10 -20 years later as a dramatic reduction in the frequency of childhood Hib meningitisassociated medically intractable temporal lobe epilepsy, as noted in many epilepsy centers during the past decade. The Hib vaccine may be the first widely used "antiepilepsy" therapy.
Depending on the final results of the FEBSTAT and similar studies, we may gain a greater understanding of the fundamental mechanisms and ultimate outcome of childhood febrile status epilepticus. This knowledge may lead to development of a treatment, perhaps an antiviral therapy or vaccine directed against HHV6/7, used in specific populations or in general, that prevents epilepsy in a significant number of people.
